|
|
||||||||
Department of Anesthesiology, Duke University Medical Center, Box 3094 DUMC, Durham, NC 27710
(Email: staff002@mc.duke.edu).
| The first 20% of the full text of this article appears below. |
The race is on to identify, beyond serum creatinine, one or more ideal early biomarkers for acute kidney injury (AKI). Few or no equivalents to creatine kinase MB, troponin, and the ST segment for the heart exist for the kidney. Many believe that the lack of tools to quickly diagnose AKI or monitor renal angina must take partial blame for the frustratingly slow development of renoprotective therapies relative to cardioprotective therapies. Much like acute myocardial infarction, AKI is now being viewed as a threshold diagnosis whose treatment paradigm demands prompt intervention.
Ristikankare
Related Article
Ann. Thorac. Surg. 2010 89: 689-694.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |